| Item | Amount | Y/Y |
|---|---|---|
| Revenue | ¥5.13B | +16.7% |
| Gross profit | ¥0.95B | — |
| Operating income | ¥0.13B | — |
| Net income | ¥0.13B | -34.0% |
| Gross margin | 18.5% | Net margin 2.5% |
| Revenue Q/Q | -3.3% | — |
The filing did not disclose a revenue breakdown for this period.
| Item | Amount | % of revenue |
|---|---|---|
| Cost of revenue | ¥4.18B | 81.5% |
| R&D | ¥0.38B | 7.5% |
| SG&A | ¥0.30B | 5.9% |
| Tax & other | ¥0.00B | 0.1% |
The Sankey chart shows how revenue splits into cost of revenue, R&D and SG&A, and what remains as profit — clean visuals for research decks and social posts.
东方日升 ・ 瑞普生物 ・ 经纬辉开 ・ 阳谷华泰 ・ ST亚光 ・ *ST聆达 ・ 锐奇股份 ・ 银河磁体 ・ 锦富技术 ・ 泰胜风能 ・ 新国都 ・ 英唐智控
Source: Eastmoney · This page shows public filing data only, not investment advice. · Browse all companies